At-Home Ketamine vs IV Infusions: How Mindbloom Compares

Quick Comparison of Mindbloom and IV Ketamine

The primary difference between Mindbloom and IV ketamine is the cost, treatment setting and the overall care model. Mindbloom provides a clinician-supervised at-home program with built-in integration coaching, while IV ketamine involves in-person infusions at a medical clinic. Both approaches offer distinct advantages depending on your clinical needs, budget, and logistical preferences.

Ketamine has been an FDA-approved anesthetic since 1970 and has been included on the WHO Model List of Essential Medicines since 1985. Both Mindbloom and IV clinics use off-label prescribing—a widespread, legally accepted medical practice—to deliver sub-anesthetic doses for mental health conditions.²

Mindbloom vs IV Ketamine at a Glance

What Is Mindbloom?

Mindbloom is one of the largest providers of guided at-home ketamine therapy in the United States. The company delivers clinician-supervised sublingual and subcutaneous ketamine as part of a comprehensive therapeutic program, rather than operating as a prescription-only service.

Mindbloom's care model is designed to optimize your environment by combining medical oversight with robust therapeutic support. Programs are organized into 6, 12, or 18 sessions, personalized based on your clinical needs and treatment goals. Mindbloom is also currently the only at-home provider offering subcutaneous administration, which enables more consistent dosing than oral ketamine or sublingual tablets.

To date, Mindbloom has facilitated over 700,000 clinician-supervised sessions. The company has published two peer-reviewed studies evaluating the safety and effectiveness of its specific protocol at scale.

A standard Mindbloom program includes:

• Clinician consults: Telehealth visits for diagnosis, prescribing, progress management, and dosage adjustments.
• Ketamine treatments: Sublingual tablets or subcutaneous injectables shipped directly to your home.
• Guide coaching: 1:1 preparation and integration sessions with a dedicated guide.
• Unlimited guide messaging: Ongoing support between your scheduled sessions.
• Group Integration Circles: Unlimited access to peer-supported integration sessions.
• Bloombox: An experiential toolkit containing an eye mask, journal, and session essentials.
• Mindbloom App: Access to 10+ guided programs with 150+ custom soundscapes, preparation materials, and integration resources.

What Is IV Ketamine Therapy?

IV ketamine therapy is an in-clinic treatment where the medication is administered intravenously under direct medical supervision. These sessions typically take place in a specialized ketamine clinic, a psychiatric office, or an outpatient medical facility.

During an IV session, you sit or recline in a clinical setting while a nurse or medical professional monitors your vitals throughout the infusion. The intravenous delivery method provides approximately 100% bioavailability, meaning the entire dose reaches your bloodstream. Most clinics offer an initial series of infusions, often consisting of six sessions over two to three weeks, followed by maintenance infusions as needed.

IV ketamine is an established modality with decades of clinical use behind it. The primary considerations for patients are the logistics of traveling to a clinic, the higher cost per session, and the variability in what is included beyond the infusion itself.

A typical IV ketamine session involves:

• Pre-session: Medical intake, a vitals check, and a review of informed consent.
• During session: An IV line is placed, ketamine is infused over approximately 40 minutes, and on-site staff continuously monitor vitals.
• Post-session: An observation period of 30 to 60 minutes occurs, followed by a vitals recheck and clearance to leave with arranged transportation.

Mindbloom vs IV Ketamine Administration Methods

Administration method refers to how ketamine enters your body during treatment. Each route has a different bioavailability, onset time, and set of practical considerations.

Sublingual Tablets

Sublingual tablets are small lozenges held between your cheek and gums for approximately seven minutes before being spit out. With a sublingual ketamine dose, effects typically begin within 10 to 15 minutes, and the bioavailability is roughly 30%. This needle-free option is self-administered at home, though session intensity can vary slightly more than with other routes.

Subcutaneous Injection

Subcutaneous administration involves using a small insulin-type needle to inject the medication into your abdomen. The effects begin in about five minutes, and the bioavailability is 90% or higher, approaching IV levels. Mindbloom injections are currently the only at-home subcutaneous option available, and 81% of clients who have tried both tablets and injectables report that injectables are easier and preferable to use.⁸

IV Infusion

IV infusion delivers ketamine directly into your bloodstream via an intravenous line in a clinical setting. This method provides nearly 100% bioavailability and allows medical staff to execute precise, real-time dose titration. It requires travel to a clinic, the placement of an IV line, and a mandatory post-session observation period before you can be driven home.

Bioavailability is an important factor in treatment selection, but it does not determine clinical outcomes on its own. Clinical supervision, screening, defined treatment frameworks, and integration support all contribute heavily to therapeutic effectiveness.

Monitoring and Clinical Oversight for Mindbloom vs IV Clinics

Clinical oversight encompasses how each provider screens, monitors, and supports clients before, during, and after their ketamine sessions. Both models prioritize safety, but they execute their protocols differently.

IV clinics utilize on-site medical staff to monitor vitals continuously during the infusion. Blood pressure, heart rate, and oxygen saturation are tracked in real time, allowing a clinician to adjust the infusion rate or stop it immediately if necessary. Post-session observation also occurs on-site before you are cleared to leave with your arranged transportation.

Mindbloom conducts clinical oversight through telehealth consults for diagnosis, prescribing, progress evaluation, and dosage adjustments. During every at-home session, you are required to have a peer treatment monitor present—someone you choose from your own support network. This is a mandatory protocol element. You also have access to 24/7 live chat support, unlimited guide messaging, and app-guided session protocols to ensure continuous care.

Comparing the monitoring models:

• IV clinic monitoring: Continuous in-session vitals tracking, on-site medical staff, real-time dose adjustment, and in-person post-session observation.
• Mindbloom monitoring: Telehealth clinician consults, a required peer treatment monitor during every session, 24/7 live chat, and continuous access to clinical staff.

Duration, Onset, and Post-Session Experience for Mindbloom vs IV Ketamine

Session timing—including the onset of action, active duration, and the post-session transition—varies significantly by administration route and setting.

For IV ketamine, the onset is almost immediate once the infusion begins, and the active experience lasts about 40 minutes. The total clinic visit, including intake, observation, and clearance, typically takes two to three hours. You must arrange transportation home, as driving is not permitted until after a full night of sleep.

Mindbloom sublingual tablets have an onset of 10 to 15 minutes, with an active experience typically lasting between 45 and 60 minutes. Mindbloom subcutaneous injections have a faster onset of about five minutes, with a similar active duration. Both at-home methods require about two hours of total session time, including preparation and the post-session transition, but they eliminate all travel and waiting room time.

The post-session period is consistent across all routes: you must avoid driving or operating machinery until after a full night of sleep. Beyond that restriction, individual experiences vary. Some people prefer to keep their schedule clear for the day, while others feel ready to resume non-driving activities later that afternoon.

Care and Support Between Sessions for Mindbloom vs IV Clinics

Integration and between-session support refer to the preparation, coaching, and practices that happen outside of the ketamine session itself. These elements help translate acute therapeutic experiences into lasting behavioral change.

Support between sessions varies significantly among IV clinics. Some facilities pair infusions with psychotherapy, a practice known as ketamine-assisted psychotherapy (KAP). However, many clinics focus solely on the medical infusion and refer clients to external therapists for integration, meaning follow-up may be limited to periodic check-ins.

Mindbloom builds integration directly into its defined treatment framework. Each client receives 1:1 guide coaching sessions focused on preparation and integration, alongside unlimited guide messaging for ongoing support. You also have unlimited access to Group Integration Circles for peer-supported processing, and the Mindbloom App provides journaling prompts and custom soundscapes.

Ketamine temporarily modulates neural communication to create conditions for change, but integration is what helps make that change durable. This is arguably the most significant structural difference between the two models: Mindbloom builds daily Integration Circles, 1:1 guide coaching, and app-based journaling directly into every program, while most IV clinics treat integration as an optional add-on—if they offer it at all.

Mindbloom's integration components include:

• 1:1 guide coaching: Personalized preparation before sessions and integration afterward.
• Unlimited guide messaging: Continuous access to your guide between sessions.
• Group Integration Circles: Peer-supported processing with unlimited access.
• App-guided programs: Custom soundscapes, journaling, and preparation resources.

Cost and Access for Mindbloom vs IV Ketamine

Cost and accessibility are among the most common decision factors when comparing at-home ketamine therapy to IV infusions. The financial and logistical commitments differ substantially between the two models.

Individual IV ketamine infusions typically range from $400 to $800 or more per session, with a standard six-infusion series totaling $2,000 to $6,000+, and because it is off-label for mood disorders, it is rarely covered by standard insurance. Geographic access is also limited to areas with specialized clinics, requiring travel, time off work, and arranged transportation for every visit.

Mindbloom's per-session cost is approximately 60% less than typical IV ketamine clinics. A new client 6-session program is priced at $430 per month for three months, totaling $1,290. The 12-session program is $370 per month for six months ($2,220 total), and the 18-session program is $330 per month for nine months ($2,970 total). That works out to $165–$215 per session depending on program length—and every program includes clinician consults, guide coaching, and integration support, not just the medication. Mindbloom programs are HSA/FSA eligible, and the company provides superbills that you can submit for potential out-of-network reimbursement

Cost and access comparison:

• IV ketamine per session: ~$400–$800+
• Mindbloom per session: ~60% less than IV clinics
• Insurance: Neither is typically covered by standard insurance; both may offer superbills; Mindbloom is HSA/FSA eligible.
• Travel: IV requires clinic visits and arranged rides; Mindbloom requires no travel.

Safety Protocols and Screening for Mindbloom and IV Ketamine

Both at-home and in-clinic ketamine therapy require rigorous clinical screening and safety protocols. The approaches differ in their execution, not in whether safety measures exist.

Clinical screening evaluates your medical history to identify contraindications that could make ketamine therapy inappropriate. For example, ketamine can temporarily increase blood pressure and heart rate. Individuals with uncontrolled hypertension or active psychosis may not be appropriate candidates, which is why cardiovascular and psychiatric screening are critical parts of the intake process for any provider.

IV clinics typically conduct screening that includes a medical history review, a medication review, and sometimes bloodwork or an EKG. During the session, on-site staff monitor vitals continuously and can intervene immediately if blood pressure or heart rate elevate unexpectedly.

Mindbloom conducts screening via telehealth clinician consults that evaluate your medical history, psychiatric background, current medications, and treatment goals. During every session, a peer treatment monitor is required to be present, and you have access to 24/7 live chat support. Mindbloom's published safety data from over 700,000 sessions shows side effects occurring at approximately 4–5%, adverse events at less than 0.1%, and discontinuation due to adverse events at 0.4%.

Mindbloom Outcomes and Published Research

Mindbloom has published two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy to date. Both studies were published in the Journal of Affective Disorders and evaluated safety and effectiveness specifically on Mindbloom clients using the Mindbloom clinical protocol. Furthermore, Mindbloom has published retrospective real-world analyses examining outcomes for PTSD and sleep improvement.

• Mathai et al. (2024): In a peer-reviewed study of 11,441 Mindbloom clients, 89% of participants reported improvement in their symptoms. Furthermore, 56.4% met criteria for depression response, and 56.1% met criteria for anxiety response. (Read the Mindbloom blog summary).⁵
• Hull et al. (2022): In a prospective open-label study of over 1,200 Mindbloom clients, 62.8% met depression response criteria. (Read the Mindbloom blog summary).⁴
• PTSD Preprint (Swain et al. 2026): In a real-world analysis of 374 PTSD program completers, 92.2% reported symptom improvement, 79.7% met criteria for response, and 60% met the criteria for remission.
• Sleep White Paper: In a real-world analysis of 13,963 program completers, 77% reported clinically significant symptom improvement with an average improvement in sleep disturbance severity of 49%, and only 2.5% reporting worsened sleep.¹⁰

While direct comparisons across treatment modalities should be interpreted with caution due to differences in study design, patient populations, and outcome measures, Mindbloom's outcomes do provide valuable context for those considering treatment:

Mindbloom's reported depression response rates (56–63%) are comparable to or modestly exceed those reported in selected IV ketamine studies.¹ Additionally, Mindbloom's reported anxiety response rate (56.1%) is comparable to or exceeds response rates reported in selected psychotherapy trials for anxiety disorders.⁸ Finally, Mindbloom’s reported PTSD response rate (79.7%) exceeds those reported in select randomized trials of prolonged exposure therapy and sertraline for PTSD.⁹

These are protocol-specific outcomes, not general ketamine literature applied to Mindbloom. IV ketamine clinics vary in whether they publish peer-reviewed outcomes on their own specific protocols, and many rely on the broader ketamine literature when discussing expected results. Individual results may vary.

Should You Choose Mindbloom or IV Ketamine?

The right option depends entirely on your clinical needs, preferences, and circumstances. Neither modality is universally superior; they are simply different clinical approaches for different needs.

Mindbloom may be a good fit if you:

• Want a comprehensive program with built-in coaching, integration, and community support.
• Prefer the convenience and comfort of at-home sessions.
• Value having both sublingual and subcutaneous administration options.
• Want a provider with published peer-reviewed outcomes data on their own protocol.
• Are looking for a more affordable option than IV infusion clinics.

IV ketamine may be a good fit if you:

• Prefer in-person medical supervision with continuous vitals monitoring during sessions.
• Want the highest possible bioavailability (~100%) via intravenous delivery.
• Have a clinical profile that requires on-site medical oversight, as determined by a clinician.
• Have access to a reputable IV ketamine clinic near your home.
• Prefer a clinical environment for your mental health treatments.

Both options are clinically established approaches to ketamine therapy. The decision is preference-sensitive and should be shaped by your medical needs, budget, and how much therapeutic support you want around the experience itself.

Disclaimer and Safety Information

Ketamine therapy requires evaluation by a licensed clinician to determine if it is medically appropriate for you. This content is for informational purposes only and does not constitute medical advice. Individual results vary by patient and condition. If you are in crisis, please contact the 988 Suicide & Crisis Lifeline immediately.